Deals

Oculus Innovative Sciences Raises $1.35M in RDO at 24% Discount via Dawson James

By |

Oculus Innovative Sciences, Inc. (OCLS) announced that it has raised $1,351,860 in a Registered Direct transaction. The common stock was sold at $3.00 per share, an approximate 24% discount to the market price ($3.97) of OCLS at deal announcement. A series of 450,620 60-Month Warrants with an exercise price of $3.00 per share (24.43% discount) was issued to the investors in this transaction. An additional series of 1,400,000 18-Month Warrants with an exercise price of $3.63 per share (8.56% discount) was issued to the investors in this transaction. Dawson James Securities, Inc. acted as the exclusive agent on the transaction.

Deals

Cytokinetics Closes $35M CMPO at 19% Discount via Cowen, JMP, Canaccord

By |

Cytokinetics, Inc. (CYTK) announced that it has raised $35,000,000 in a CMPO/Overnight transaction. The common stock was sold at $8.00 per share, an approximate 19% discount to the market price ($9.85) of CYTK at deal announcement. Cowen and Company acted as Sole Bookrunner, with JMP Securities acting acting as Lead Manager, and Canaccord Genuity acting as Co-Manager on the transaction. Underwriter counsel was Goodwin Procter and issuer counsel was Cooley. The transaction is expected to close by 02/25/2014.

Deals

BIOLASE Raises $5M from Oracle Investment Mgt.

By |

BIOLASE, Inc. (BIOL) announced that it has raised $4,999,999 in a Common Stock transaction. The common stock was sold at $2.57 per share. Northland Securities acted as the exclusive agent on the transaction. The investor was Oracle Investment Management. Issuer counsel was Willkie, Farr & Gallagher.

Deals

Mast Therapeutics Announces $30M ATM Program via Cowen

By |

Mast Therapeutics Inc. (MSTX) announced that it has secured up to $30,000,000 in an ATM (At the Market) transaction with Cowen and Company. The purchase price is the prevailing market price at the time of the Draw Down Notice. Placement Agent counsel was LeClairRyan and issuer counsel was DLA Piper. An agreement was reached on February 10, 2014. via PlacementTracker.